Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-30

FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., signaling an update to the drug's labeling under an ANDA suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)